For services, the company will focus on parenteral dosage forms for biologics, drug conjugates, peptides and small molecules for products for injection or infusion
This is second API facility of Sequent Scientific's animal healthcare arm in India
With Sernivo spray (betamethasone dipropionate), the company is looking to expand its portfolio of medical dermatology products available in the US market
Two companies have entered into an agreement to discover rare monoclonal antibodies by using AbCellera's high-throughput single cell antibody platform
The company will join GSK-led Centre for Therapeutic Target Validation (CTTV), a public-private collaboration to improve the success rate for discovering new medicines
The company has acquired 51% stake in Australia's Generic Partners Holding and Kenya's Universal Corporation
Indian tech firm sets up incubation center, designed to leverage Microsoft Azure IoT Suite, for building solutions focused on two areas - industrial and life sciences & healthcare
The company will probably be the first in the world to file for global patent for Zika vaccine candidates
The plant will manufacture specialty chemicals used in pharmaceutical sector
With this, Abbott gains leadership in the $5.5 billion point of care segment, broadens diagnostics footprint and enhances access to fast-growing diagnostics channels
Minister urges scientists to take steps towards standardisation of ayurvedic drugs so that their use can be increased in health care
Ipca has received warning letter for its manufacturing units based at Ratlam (Madhya Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa)
Promius Pharma, the US subsidiary of Dr Reddy's Laboratories, will be responsible for commercialising Zenavod (doxycycline) capsule in the US market
Alfuzosin hydrochloride extended release tablet, a generic version of Concordia Pharmaceuticals' Uroxatral tablet, is used in treating prostatic hyperplasia
Biosimilars segment, another lucrative market in Indian pharmaceutical sector, is expected to increase to $40 billion globally by 2020, as per GlobalData report
The company has received US FDA's green signal for celecoxib capsules (used for treating pain and inflammation) and levetiracetam injection (an epilepsy drug)
The company, which received final approval for imatinib mesylate from US FDA in December 2015, also has 180 days of marketing exclusivity for being a first-to-file product
This transaction will enable Aptar Group to tap the airless dispensing systems market
The deal, worth Rs 163.5 crore, will strengthen the presence of Germany's Munich Re in India which is one of the key markets for the company
With metros saturated with big multi-specialty hospitals, tier II cities and smaller towns, which have substantial populations, offer huge opportunity for private hospitals